|
Dietary inflammatory index and breast cancer risk by menopausal status and histological subtype. |
|
|
No Relationships to Disclose |
|
|
Other Relationship - Connecting Health Innovations |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Roche |
|
Expert Testimony - Novartis |
Travel, Accommodations, Expenses - Roche |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Lilly; Novartis; Pfizer; Roche/Genentech |
Research Funding - Novartis (Inst); Roche (Inst) |
|
|
No Relationships to Disclose |